Sorry, we do not have enough data to show an influence graph for this author.
- Full text PDF available (0)
Journals and Conferences
The objective of this phase II and pharmacologic study was to explore the feasibility, toxicity and activity of adaptive intrapatient dose escalation of cisplatin in a dose-intensive weekly schedule… (More)
In the present study we describe the toxicity of weekly high-dose (70–85 mg m−2) cisplatin in 400 patients (203 men, 197 women; median age 54 years) with advanced solid tumours treated in the period… (More)